Jeyakumar, Ghayathri <br/><br/>
Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy.  [electronic resource] 

 -  Journal for immunotherapy of cancer  10 2017 
 - 82 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2051-1426 
<br/><br/><label>Standard No.: </label>10.1186/s40425-017-0287-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Renal Cell--blood<br/>Female<br/>Humans<br/>Kidney Neoplasms--blood<br/>Lymphocytes--metabolism<br/>Male<br/>Middle Aged<br/>Neutrophils--metabolism<br/>Protein Kinase Inhibitors--pharmacology<br/>Treatment Outcome<br/>Young Adult